Allovir Cash Per Share vs. Debt To Equity

ALVR Stock  USD 0.55  0.02  3.51%   
Considering Allovir's profitability and operating efficiency indicators, Allovir may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Allovir's ability to earn profits and add value for shareholders.
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
1.76771385
Current Value
1.68
Quarterly Volatility
3.26443965
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Allovir's Price To Sales Ratio is relatively stable compared to the past year. As of 11/26/2024, Days Sales Outstanding is likely to grow to 1,171, though Operating Cash Flow Sales Ratio is likely to grow to (133.45). At this time, Allovir's Net Interest Income is relatively stable compared to the past year. As of 11/26/2024, Interest Income is likely to grow to about 5.5 M, though Operating Income is likely to grow to (172.3 M).
For Allovir profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Allovir to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Allovir utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Allovir's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Allovir over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Allovir Stock, please use our How to Invest in Allovir guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allovir. If investors know Allovir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allovir listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.90)
Return On Assets
(0.37)
Return On Equity
(0.80)
The market value of Allovir is measured differently than its book value, which is the value of Allovir that is recorded on the company's balance sheet. Investors also form their own opinion of Allovir's value that differs from its market value or its book value, called intrinsic value, which is Allovir's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allovir's market value can be influenced by many factors that don't directly affect Allovir's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allovir's value and its price as these two are different measures arrived at by different means. Investors typically determine if Allovir is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allovir's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Allovir Debt To Equity vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Allovir's current stock value. Our valuation model uses many indicators to compare Allovir value to that of its competitors to determine the firm's financial worth.
Allovir is rated below average in cash per share category among its peers. It is rated below average in debt to equity category among its peers fabricating about  0.07  of Debt To Equity per Cash Per Share. The ratio of Cash Per Share to Debt To Equity for Allovir is roughly  13.45 . At this time, Allovir's Cash Per Share is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Allovir by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Allovir Debt To Equity vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Allovir

Cash Per Share

 = 

Total Cash

Average Shares

 = 
1.91 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Allovir

D/E

 = 

Total Debt

Total Equity

 = 
0.14 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Allovir Debt To Equity Comparison

Allovir is currently under evaluation in debt to equity category among its peers.

Allovir Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Allovir, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Allovir will eventually generate negative long term returns. The profitability progress is the general direction of Allovir's change in net profit over the period of time. It can combine multiple indicators of Allovir, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-62 K-65.1 K
Net Interest Income5.3 M5.5 M
Interest Income5.3 M5.5 M
Operating Income-181.3 M-172.3 M
Net Loss-168.9 M-160.4 M
Income Before Tax-190.5 M-181 M
Total Other Income Expense Net-9.2 M-8.8 M
Net Loss-151.8 M-144.2 M
Net Loss-190.4 M-180.9 M
Income Tax Expense-126 K-132.3 K
Non Operating Income Net Other2.6 M2.7 M
Change To Netincome47.5 M49.9 M
Net Loss(1.83)(1.92)
Income Quality 0.65  0.41 
Net Income Per E B T 1.00  0.78 

Allovir Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Allovir. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Allovir position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Allovir's important profitability drivers and their relationship over time.

Use Allovir in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.

Allovir Pair Trading

Allovir Pair Trading Analysis

The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Allovir position

In addition to having Allovir in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Allovir Stock Analysis

When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.